For researchers, this review provides new information on how the crosstalk between adipokines such as adiponectin and hepatokines such as fetuin-A and FGF21 may be independently involved in the pathogenesis of MASLD. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.